Table 2.
Characteristic | Breast | Colorectal | Lung | Prostate | Overall |
---|---|---|---|---|---|
N | 124 253 | 52 383 | 51 311 | 94 940 | 322 887 |
Age [mean (SD)] | 59.5 (12.1) | 63.2 (12.5) | 67.1 (10.5) | 66.9 (9.1) | 63.5 (11.6) |
Sex [n (%)] | |||||
Male | – | 27 616 (52.7%) | 27 170 (53.0%) | 94 940 (100.0%) | 149 726 (46.4%) |
Female | 124 253 (100.0%) | 24 767 (47.3%) | 24 141 (47.0%) | – | 173 161 (53.6%) |
Race/Ethnicity [n (%)] | |||||
Missing/Unknown | 37 198 (29.9%) | 18 961 (36.2%) | 19 432 (37.9%) | 32 741 (34.5%) | 108 332 (33.6%) |
Asian | 2398 (1.9%) | 862 (1.6%) | 634 (1.2%) | 1019 (1.1%) | 4913 (1.5%) |
Black | 9543 (7.7%) | 3847 (7.3%) | 3538 (6.9%) | 7920 (8.3%) | 24 848 (7.7%) |
Hispanic | 5491 (4.4%) | 2360(4.5%) | 1271 (2.5%) | 3463 (3.6%) | 12 585 (3.9%) |
White | 69 623 (56.0%) | 26 353 (50.3%) | 26 436 (51.5%) | 49 797 (52.5%) | 172 209 (53.3%) |
Annual household income [n (%)] | |||||
Unknown | 44 997 (36.2%) | 22 584 (43.1%) | 23 569 (45.9%) | 37 349 (39.3%) | 128 499 (39.8%) |
<$25K | 15 627 (12.6%) | 6713 (12.8%) | 8845 (17.2%) | 10 733 (11.3%) | 41 918 (13.0%) |
$24K ‐ $149K | 19 793 (15.9%) | 8511 (16.2%) | 8488 (16.5%) | 15 694 (16.5%) | 52 416 (16.2%) |
$150K ‐ 249K | 23 057 (18.6%) | 8367 (16.0%) | 6551 (12.8%) | 17 314 (18.2%) | 55 289 (17.1%) |
$250K ‐ $499K | 12 336 (9.9%) | 3964 (7.6%) | 2553 (5.0%) | 8514 (9.0%) | 27 367 (8.5%) |
$500K+ | 8513 (6.9%) | 2244 (4.3%) | 1305 (2.5%) | 5336 (5.6%) | 17 398 (5.4%) |
Education [n (%)] | |||||
Missing/Unknown | 34 322 (27.6%) | 17 925 (34.2%) | 18 449 (36.0%) | 30 698 (32.3%) | 101 394 (31.4%) |
Less than 12th grade | 217 (0.2%) | 141 (0.3%) | 89 (0.2%) | 149 (0.2%) | 596 (0.2%) |
High school diploma | 20 749 (16.7%) | 9891(18.9%) | 10 987 (21.4%) | 16 468 (17.3%) | 58 095 (18.0%) |
Less than bachelor degree | 48 901 (39.4%) | 18 423 (35.2%) | 17 365 (33.8%) | 35 020 (36.9%) | 119 709 (37.1%) |
Bachelor degree plus | 20 064 (16.1%) | 6003 (11.5%) | 4421 (8.6%) | 12 605 (13.3%) | 43 093 (13.3%) |
Insurance type [n (%)] | |||||
Private insurance | 99 932 (80.4%) | 42 456 (81.0%) | 37 196 (72.5%) | 69 486 (73.2%) | 249 070 (77.1%) |
Medicare Advantage | 24 321 (19.6%) | 9927 (19.0%) | 14 115 (27.5%) | 25 454 (26.8%) | 73 817 (22.9%) |
Clinical characteristics | |||||
Metastatic disease [n (%)] | 26 791 (21.6%) | 18 671 (35.6%) | 30 169 (58.8%) | 10 800 (11.4%) | 86 431 (26.8%) |
Charlson index* [mean (SD)] | 2.0 (1.6) | 2.8 (1.9) | 3.6 (1.8) | 2.8 (1.4) | 2.6 (1.7) |
Rehospitalized w/in 1 y [n (%)] | 36 780 (29.6%) | 33 047 (63.1%) | 32 092 (62.5%) | 37 798 (39.8%) | 139 717 (43.3%) |
Hospital days [mean (SD)] | 5.1 (8.8) | 10.4 (13.9) | 10.4 (12.9) | 4.1 (7.9) | 7.3 (11.4) |
Treatment type [n (%)] | |||||
Chemotherapy only | 18 357 (14.8%) | 8724 (16.7%) | 11 501 (22.4%) | 18 830 (19.8%) | 57 412 (17.8%) |
Radiation only | 11 407 (9.2%) | 1273 (2.4%) | 7260 (14.1%) | 21 253 (22.4%) | 41 193 (12.8%) |
Surgery only | 22 952 (18.5%) | 22 770 (43.5%) | 6818 (13.3%) | 31 598 (33.3%) | 84 138 (26.1%) |
Multimodality | 71 537 (57.6%) | 19 616 (37.4%) | 25 732 (50.1%) | 23 259 (24.5%) | 140 144 (43.4%) |
Percentages may not add to 100% due to rounding.
NIH measure for cancer patients’ modification. https://healthcaredelivery.cancer.gov/seermedicare/considerations/calculation.html.